Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Appointed director
Consulting agrmnt
Director departure
|
|
THERALINK TECHNOLOGIES, INC. (OBMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2022 |
4
| Schwartz Matthew Wilson (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Acquired convertible notes
@ $0.0048, valued at
$0
Acquired 4,201,681 warrants
@ $0.0048, valued at
$20.2k
Granted 5,191,080 options to buy
@ $0.0036, valued at
$18.7k
|
|
| 09/22/2022 |
4
| FORS YVONNE (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 6,488,851 options to buy
@ $0.0036, valued at
$23.4k
|
|
| 09/21/2022 |
4
| Busch Jeffrey (Chairman of the Board) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 469,738,712 options to buy
@ $0.0036, valued at
$1.7M
|
|
| 09/21/2022 |
4
| Chilcott, III Thomas E. (CFO) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 94,545,096 options to buy
@ $0.0036, valued at
$340.4k
|
|
| 09/21/2022 |
4
| RUXIN MICHAEL I (CEO) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Granted 469,738,712 options to buy
@ $0.0036, valued at
$1.7M
|
|
| 06/22/2022 |
4
| Holley Danica (Director) has filed a Form 4 on THERALINK TECHNOLOGIES, INC.|
Txns:
| Acquired convertible notes
@ $0.0048, valued at
$0
Acquired 2,100,840 warrants
@ $0.0048, valued at
$10.1k
|
|
| 06/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2022 |
3
| Holley Danica (Director) has filed a Form 3 on THERALINK TECHNOLOGIES, INC. |
| 10/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
3
| RUXIN MICHAEL I (CEO) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
| 06/15/2020 |
3
| Avant Diagnostics, Inc (10% Owner) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
| 06/09/2020 |
4
| KUCHARCHUK ANDREW ALBERT (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 241 convertible preferred
@ $0.0001, valued at
$0 |
|
| 05/08/2020 |
4
| KUCHARCHUK ANDREW ALBERT (CEO and CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 283,334 shares
@ $0.06, valued at
$17k
|
|
| 05/08/2020 |
4
| HEAD JONATHAN FREDERICK (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 166,667 shares
@ $0.06, valued at
$10k
|
|
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4/A
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 350,000 options to buy
@ $0.27, valued at
$94.5k
|
|
| 03/14/2019 |
4/A
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 350,000 options to buy
@ $0.27, valued at
$94.5k
|
|
| 03/14/2019 |
3/A
| Barnett Brian Gill (CEO) has filed a Form 3/A on OncBioMune Pharmaceuticals, Inc |
| 03/14/2019 |
4/A
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 2,000,000 options to buy
@ $0.25, valued at
$500k
|
|
| 03/14/2019 |
4/A
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 500,000 shares
@ $0 |
|
| 03/14/2019 |
3/A
| HOLCOMB ROBERT NEAL (Director) has filed a Form 3/A on OncBioMune Pharmaceuticals, Inc |
| 03/14/2019 |
4/A
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
Granted 2,000,000 options to buy
@ $0.25, valued at
$500k
|
|
| 01/07/2019 |
3
| Barnett Brian Gill (CEO) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
| 05/22/2018 |
3
| HOLCOMB ROBERT NEAL (Director) has filed a Form 3 on OncBioMune Pharmaceuticals, Inc |
| 05/11/2018 |
4
| KUCHARCHUK ANDREW ALBERT (CFO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| HEAD JONATHAN FREDERICK (CEO) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| Hoverman Daniel S. (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 05/11/2018 |
4
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc|
Txns:
| Granted 3,000,000 options to buy
@ $0.0135, valued at
$40.5k
|
|
| 04/20/2017 |
4
| RICE CHARLES L JR (Director) has filed a Form 4 on OncBioMune Pharmaceuticals, Inc |
|
|
|